axicabtagene ciloleucel

nuclear receptor subfamily 1 group I member 3 ; Homo sapiens







5 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32007196 CAR T-cell product performance in haematological malignancies before and after marketing authorisation. 2020 Feb 1
2 32064069 Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas. 2020 1
3 32067497 Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy. 2020 Jun 2
4 31648957 Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma. 2019 Dec 1
5 31723824 CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope. 2019 Apr 1